Security key
63008J702
NanoVibronix, Inc. - COMMON STOCK, $0.001 PAR VALUE PER SHARE (NAOV)
CUSIP: 63008J702
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK, $0.001 PAR VALUE PER SHARE
- Total 13F shares
- 19,503
- Total 13F value
- $18,080
- Share change
- -294
- SEC-reported price per share
- $0.93
- Number of holders
- 7
- Value change
- -$273
- Number of buys
- 5
- Number of sells
- 1
- Shares outstanding
- 825,536
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
7
Top holders
7
NAOV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
ENvue Medical, Inc. SEC filings
ENvue Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63008J702
Recent filing periods:
Ownership snapshot
Top reported holders of NAOV - NanoVibronix, Inc. - COMMON STOCK, $0.001 PAR VALUE PER SHARE (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ALPHA CAPITAL ANSTALT
Disclosed value leader
ALPHA CAPITAL ANSTALT
Comparable rows
6/15
Latest evidence
16 May 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
9 rows are not safely comparable across share classes.
13D/G row: ALPHA CAPITAL ANSTALT
Showing 1-6 of 15 holder rows.
Quick read
ALPHA CAPITAL ANSTALT leads the comparable SEC ownership view at 10%.
6 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ALPHA CAPITAL ANSTALT's linked filing trail.
Comparable ownership
Top 5
ALPHA CAPITAL ANSTALT
10%
ARMISTICE CAPITAL, LLC
5%
MORGAN STANLEY
1.6%
UBS Group AG
0.63%
Tower Research Capital LLC (TRC)
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ALPHA CAPITAL ANSTALT |
13D/G
|
10%
|
$305,967
82,471 shares
|
$0 | 16 May 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$147,947
39,878 shares
|
$0 | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
1.6%
|
$46,427
13,615 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.63%
|
$17,595
5,160 shares
|
— | 31 Mar 2025 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.12%
|
$3,461
1,015 shares
|
— | 31 Mar 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$24
7 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
19,503
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
4
Q2 2025 holders
7
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend